Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05115916 · ClinicalTrials.gov registry record · NA
Effect of Patient Portal Messaging Before Mailing Fecal Immunochemical Testing Kit on Colorectal Cancer Screening Rates
A NA study of Colorectal Cancer and Colorectal Neoplasms, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 3,880
- Enrollment target
- 1
- Study location
NCT05115916: Completed NA study of Colorectal Cancer and Colorectal Neoplasms, sponsored by University of California, Los Angeles.
NCT05115916 is a NA study of Colorectal Cancer and Colorectal Neoplasms that has completed, run by University of California, Los Angeles. The registered enrollment target is 3,880 participants, above the 1,534-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (153% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05115916, a NA study of Colorectal Cancer and Colorectal Neoplasms, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,880 participants
- Enrollment target
- 1
- Study location
Study Summary
Behavioral economics principles have increasingly been shown to improve health outcomes in the United States. They offer the ability to implement simple, low-cost and effective interventions to address key health issues without sacrificing the autonomy of patients. Colorectal cancer (CRC) screening is a key area where behavioral economics principles can help improve health outcomes. Despite being the second leading cause of cancer related death, the rate of CRC screening remains well below national targets. Interventions to address these issues, and improve screening rates at our institution have including implementing a Mailed FIT outreach program, and adding an informational letter that utilizes behavioral economic principles. To further improve our screening rates, this project builds upon our previous efforts to include a randomized electronic message primer via patients electronic patient portal, to help alert them of incoming FIT Kit and complete screening. This study will contribute to the growing literature of behavioral economics in medicine, while addressing an important health issue.
Primary Outcome
Rate of completion of CRC screening by any of the following: FIT, colonoscopy, CT colonography, sigmoidoscopy or FIT-DNA within study period.
Conditions Studied
Interventions
- BEHAVIORAL MyChart Priming Message
Study Locations (1)
California
- UCLA Health Department of Medicine, Quality Office - Westwood, Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,880 participants |
| Start Date | 2019-08-28 |
| Est. Completion | 2020-12-20 |
| Phase | NA |
What the finished NCT05115916 record still lists
NCT05115916 is an interventional study that assigns participants to a tested intervention. Its 3,880 participants enrollment target places it among the larger protocols in the corpus, above the 1,534-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (153% higher).
The record links to 3 conditions, with Colorectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which MyChart Priming Message is the first listed.
NCT05115916 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05115916 about?
NCT05115916 is a clinical study titled "Effect of Patient Portal Messaging Before Mailing Fecal Immunochemical Testing Kit on Colorectal Cancer Screening Rates". Behavioral economics principles have increasingly been shown to improve health outcomes in the United States. They offer the ability to implement simple, low-cost and effective interventions to address key health issues without sacrificing the autonomy of patients. Colorectal cancer (CRC) screening ...
What is the current status of trial NCT05115916?
This trial is currently completed. It is a NA study. The enrollment target is 3,880 participants. The study started on 2019-08-28. Estimated completion is 2020-12-20.
What conditions does trial NCT05115916 study?
This clinical trial studies the following conditions: Colorectal Cancer, Colorectal Neoplasms, Colorectal Cancer Screening.
What interventions are being tested in trial NCT05115916?
The interventions under investigation include: MyChart Priming Message (BEHAVIORAL).
Who is sponsoring clinical trial NCT05115916?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05115916 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05115916's enrollment target sits among peer trials
3,880 21st of 381 higher than 361 of 381 other Colorectal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
RECRUITING · NA
-
Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer
RECRUITING · NA
-
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05919342 · 3,904 participants · NA
Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"
- NCT07087613 · 3,850 participants
Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG
- NCT03936335 · 3,930 participants
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)
- NCT05879926 · 3,960 participants · Phase 3
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI